M. DEMİRBÜGEN Et Al. , "5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment," Turk Heltox Toxicology Congress , 2015
DEMİRBÜGEN, M. Et Al. 2015. 5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment. Turk Heltox Toxicology Congress .
DEMİRBÜGEN, M., UÇKUN, Z., YÜCE, N., BASKAK, B., & SÜZEN, H. S., (2015). 5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment . Turk Heltox Toxicology Congress
DEMİRBÜGEN, MERVE Et Al. "5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment," Turk Heltox Toxicology Congress, 2015
DEMİRBÜGEN, MERVE D. Et Al. "5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment." Turk Heltox Toxicology Congress , 2015
DEMİRBÜGEN, M. Et Al. (2015) . "5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment." Turk Heltox Toxicology Congress .
@conferencepaper{conferencepaper, author={MERVE DEMİRBÜGEN ÖZ Et Al. }, title={5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment}, congress name={Turk Heltox Toxicology Congress}, city={}, country={}, year={2015}}